Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00711737|
Recruitment Status : Completed
First Posted : July 9, 2008
Last Update Posted : June 17, 2011
|Condition or disease|
|Major Depression Generalized Anxiety Disorder Panic Disorder|
This is an open-label study, with 4 scheduled visits. Recruitment of 100 subjects. Assessments include demographics, diagnosis, smoking frequency, Clinical Global Scale (CGI-S), weight, height,blood pressure, waist and hip circumference and fasting blood glucose and lipd profile.
Statistical analysis will be exploratory and mainly descriptive.
|Study Type :||Observational|
|Actual Enrollment :||27 participants|
|Official Title:||Open-label Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months|
|Study Start Date :||September 2008|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||October 2010|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00711737
|Changi General Hospital|
|Singapore, Singapore, 529889|
|Principal Investigator:||Lai H Peh, MBBS||Changi General Hospital|